BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 18287557)

  • 1. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic toxins: do we know enough to explain uremia?
    Vanholder R; Meert N; Schepers E; Glorieux G
    Blood Purif; 2008; 26(1):77-81. PubMed ID: 18182802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
    Vanholder R; Van Laecke S; Glorieux G
    J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF; Audia PF
    Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anglerfish and uremic toxins.
    Lowenstein J
    FASEB J; 2011 Jun; 25(6):1781-5. PubMed ID: 21622695
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on uremic toxins.
    Ringoir S
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and metabolic consequences of uremic toxicity].
    Rutkowski P
    Przegl Lek; 2006; 63(4):209-17. PubMed ID: 17080744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uremic toxins: the case of protein-bound compounds].
    Basile C; Libutti P; Teutonico A; Lomonte C
    G Ital Nefrol; 2010; 27(5):498-507. PubMed ID: 20922681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of uremic toxin research by mass spectrometry.
    Niwa T
    Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is new in uremic toxicity?
    Vanholder R; Van Laecke S; Glorieux G
    Pediatr Nephrol; 2008 Aug; 23(8):1211-21. PubMed ID: 18324423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 18. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From uremic toxin retention to removal by convection: do we know enough?
    Vanholder R; Meert N; Schepers E; Glorieux G
    Contrib Nephrol; 2008; 161():125-131. PubMed ID: 18451668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.